CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 647594-647778 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T76456","span":{"begin":0,"end":184},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A large, open-label, azelastine (Astelin) nasal spray patient experience trial was conducted in patients with SAR, VMR, or mixed rhinitis (allergic rhinitis with nonallergic triggers)."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T152","span":{"begin":0,"end":184},"obj":"Sentence"}],"text":"A large, open-label, azelastine (Astelin) nasal spray patient experience trial was conducted in patients with SAR, VMR, or mixed rhinitis (allergic rhinitis with nonallergic triggers)."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5995","span":{"begin":79,"end":82},"obj":"Disease"},{"id":"T5996","span":{"begin":129,"end":137},"obj":"Disease"},{"id":"T5997","span":{"begin":139,"end":156},"obj":"Disease"},{"id":"T5998","span":{"begin":139,"end":147},"obj":"Disease"},{"id":"T5999","span":{"begin":148,"end":156},"obj":"Disease"}],"attributes":[{"id":"A5995","pred":"mondo_id","subj":"T5995","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"id":"A5996","pred":"mondo_id","subj":"T5996","obj":"http://purl.obolibrary.org/obo/MONDO_0003014"},{"id":"A5997","pred":"mondo_id","subj":"T5997","obj":"http://purl.obolibrary.org/obo/MONDO_0011786"},{"id":"A5998","pred":"mondo_id","subj":"T5998","obj":"http://purl.obolibrary.org/obo/MONDO_0004980"},{"id":"A5999","pred":"mondo_id","subj":"T5999","obj":"http://purl.obolibrary.org/obo/MONDO_0003014"}],"text":"A large, open-label, azelastine (Astelin) nasal spray patient experience trial was conducted in patients with SAR, VMR, or mixed rhinitis (allergic rhinitis with nonallergic triggers)."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T3192","span":{"begin":129,"end":137},"obj":"Phenotype"},{"id":"T3193","span":{"begin":139,"end":156},"obj":"Phenotype"}],"attributes":[{"id":"A3192","pred":"hp_id","subj":"T3192","obj":"http://purl.obolibrary.org/obo/HP_0012384"},{"id":"A3193","pred":"hp_id","subj":"T3193","obj":"http://purl.obolibrary.org/obo/HP_0003193"}],"text":"A large, open-label, azelastine (Astelin) nasal spray patient experience trial was conducted in patients with SAR, VMR, or mixed rhinitis (allergic rhinitis with nonallergic triggers)."}